- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02694120
Study on Complications, EfficAcy and Costs of Large Polypectomy (SCALP)
Colonoscopy has been shown to reduce the incidence and mortality of colorectal cancer, through the recognition and removal of pre-cancerous lesions, which in most cases evolve with a sequence that goes through formation of high-grade dysplasia (HGD).
The probability of HGD increases with the increase of the lesion of the polyp itself. Lesions> 2 cm are present in 1% of colonoscopy screening. The resection of these lesions presents a greater technical difficulty and consequently a decrease in the efficiency. The rate of incomplete resection reported in the literature reaches 10% while that of recurrence / residual adenoma 16.4 / 31.7%.
The aim of the study SCALP is to evaluate the incidence of complications, efficacy and cost of endoscopic resection of colic lesions> 2cm in a setting of clinical practice in an unselected population
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- adult patients undergoing large endoscopic polypectomy
Exclusion Criteria:
- pregnancy
- incapacity to give informed consent
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
colonoscopy population
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
complications of large polypectomy
Time Frame: 15 days
|
incidence of polypectomy-related adverse events
|
15 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
costs of large polypectomy
Time Frame: 15 days
|
assessment of the average cost per procedure, including devices and staff costs
|
15 days
|
|
efficacy of large polypectomy
Time Frame: 6 months
|
assessment of residual adenoma at follow-up
|
6 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2016.2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Polypectomy
-
Valduce HospitalTerminated
-
VA Office of Research and DevelopmentCompletedPolypectomy | Post-polypectomy Bleeding | Elective ColonoscopyUnited States
-
Valduce HospitalCompletedEndoscopic Polypectomy
-
AstraZenecaJohnson & Johnson K.K. Medical CompanyCompletedGastrointestinal Endoscopy | Gastrointestinal PolypectomyJapan
-
Ningbo No. 1 HospitalCompletedPolypectomy SnareChina
-
Showa Inan General HospitalCompletedPostpolypectomy Bleeding | Diminutive Colorectal Polyp | Cold Snare Polypectomy | Polypectomy Snare | Complete Resection RateJapan
-
AstraZenecaJohnson & JohnsonCompletedSedation to be Moderate for a Diagnostic Gastrointestinal Endoscopy and Gastrointestinal Endoscopic PolypectomyJapan
-
Dallas VA Medical CenterCompletedColonoscopy | Post-polypectomy Bleeding | Anti-platelet TherapyUnited States
-
Chinese University of Hong KongRecruitingPost Polypectomy BleedingHong Kong
-
Camlıca Erdem HospitalCompleted